Rat Model

Global Rat Model Market to Reach US$2.8 Billion by 2030

The global market for Rat Model estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Inbred, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$901.6 Million by the end of the analysis period. Growth in the Outbred segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$516.5 Million While China is Forecast to Grow at 6.7% CAGR

The Rat Model market in the U.S. is estimated at US$516.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$439.9 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Rat Model Market - Key Trends and Drivers Summarized

Rat Model: A Crucial Tool in Biomedical Research

Rat models are a cornerstone of biomedical research, widely used for studying a range of human diseases and testing potential treatments. The physiological and genetic similarities between rats and humans make them valuable models for understanding disease mechanisms, evaluating drug efficacy, and studying toxicology. Rats are particularly favored in research areas such as neuroscience, cardiovascular diseases, and metabolic disorders, where their larger size compared to mice allows for more complex surgical procedures and the collection of multiple tissue samples. The development of genetically modified rat models has further enhanced their utility, enabling researchers to study specific genes and their roles in disease processes. The insights gained from rat model studies are crucial for the development of new therapies and for advancing our understanding of human health and disease.

How Are Technological Advances Enhancing the Use of Rat Models in Research?

Technological advances are significantly enhancing the use of rat models in biomedical research, making them more precise and relevant to human conditions. The development of advanced genetic engineering techniques, such as CRISPR-Cas9, has enabled the creation of rat models with specific gene knockouts or knock-ins, allowing researchers to study the effects of precise genetic changes on disease development and progression. Imaging technologies, such as MRI and PET, are being increasingly used in conjunction with rat models to non-invasively monitor disease processes and treatment responses in real-time. Additionally, the integration of omics technologies, including genomics, proteomics, and metabolomics, is providing a more comprehensive understanding of the molecular changes occurring in rat models during disease progression. These advancements are making rat models more powerful and relevant tools in the study of human diseases, accelerating the pace of biomedical research and drug development.

What Are the Key Applications and Benefits of Using Rat Models in Research?

Rat models are used in a wide range of research applications, offering numerous benefits that make them indispensable tools in biomedical science. In neuroscience research, rat models are used to study brain function, behavior, and neurological disorders such as Parkinson’s disease, Alzheimer’s disease, and epilepsy. Their larger brain size compared to mice allows for more detailed anatomical and functional studies. In cardiovascular research, rat models are essential for studying heart disease, hypertension, and stroke, providing insights into the mechanisms of these conditions and the effects of potential treatments. In toxicology and pharmacology, rat models are used to assess the safety and efficacy of new drugs, helping to identify potential side effects and optimal dosing regimens. The primary benefits of using rat models include their physiological similarity to humans, their ability to undergo complex surgical procedures, and the wealth of genetic and biological data available from decades of research. These advantages make rat models a vital resource for advancing our understanding of human diseases and developing new therapies.

What Factors Are Driving the Growth in the Rat Model Market?

The growth in the Rat Model market is driven by several factors. The increasing demand for reliable and physiologically relevant animal models in biomedical research is a significant driver, as researchers seek to better understand human diseases and develop new treatments. Technological advancements in genetic engineering and imaging are also propelling market growth by enhancing the capabilities and applications of rat models. The rise of personalized medicine and the need for models that can replicate human genetic diversity are further boosting demand for genetically modified rat models. Additionally, the expansion of research in fields such as neuroscience, cardiovascular diseases, and oncology is contributing to market growth, as these areas heavily rely on rat models for preclinical studies. The growing investment in biomedical research and the increasing focus on translational research, which aims to bridge the gap between laboratory findings and clinical applications, are also supporting the growth of the rat model market. These factors, combined with ongoing innovation in animal model development, are driving the sustained growth of this market.

SCOPE OF STUDY:

The report analyzes the Rat Model market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Rat Type (Inbred, Outbred, Knockout, Hybrid, Other Rat Types); Technology (CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection, Other Technologies); Application (Research & Development , Production & Quality Control, Academics, Other Applications); End-Use (Human, Veterinary)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

• Biomere
• Charles River Laboratories International, Inc.
• Covance, Inc.
• Envigo, Inc.
• Genoway S.A.
• Horizon Discovery Group PLC
• Janvier Labs
• Taconic Biosciences, Inc.
• Transposagen Biopharmaceuticals, Inc.
• Transviragen, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.